From: Research trends and hotspots of recurrent pregnancy loss with thrombophilia: a bibliometric analysis
Rank | Document | Title | Journal | Citations |
---|---|---|---|---|
1 | Rey [19] | Thrombophilic disorders and fetal loss: a meta-analysis | Lancet | 585 |
3 | Regan (2000) | Recurrent miscarriage - an aspirin a day? | Human Reproduction | 322 |
4 | Kaandorp (2010) | Aspirin plus Heparin or Aspirin Alone in Women with Recurrent Miscarriage | New England Journal of Medicine | 289 |
5 | Keeling [31] | Guidelines on the investigation and management of antiphospholipid syndrome | British Journal of Haematology | 278 |
6 | Haverkate (1995) | Familial dysfibrinogenemia and thrombophilia. Report on a study of the SSC Subcommittee on Fibrinogen | Thromb Haemost | 264 |
7 | Martinelli (2000) | Mutations in coagulation factors in women with unexplained late fetal loss | New England Journal of Medicine | 253 |
8 | Brenner [29] | Gestational outcome in thrombophilic women with recurrent pregnancy loss treated by enoxaparin | Thrombosis and Haemostasis | 239 |
9 | Laskin (2009) | Low Molecular Weight Heparin and Aspirin for Recurrent Pregnancy Loss: Results from the Randomized, Controlled HepASA Trial | Journal of Rheumatology | 232 |
10 | grandone (1997) | Factor V Leiden is associated with repeated and recurrent unexplained fetal losses | Thrombosis and Haemostasis | 231 |